Johnson & Johnson stock rises on talc-court ruling — FDA Class I recall keeps JNJ in focus
Johnson & Johnson shares ticked up on Friday, holding steady into after-hours. Investors weighed a New Jersey court’s latest move in the company’s ongoing talc litigation, along with a new FDA safety notice tied to select devices.